Immunotherapy in Glioblastoma: An Overview of Current Status
Zouina Sarfraz,1 Arun Maharaj,1 Vyshak Alva Venur,2 Justin D Lathia,3 Yazmin Odia,1 Manmeet S Ahluwalia1,4 1Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA; 2Seattle Cancer Care Alliance, Fred Hutchinson Cancer Center, University of Washington, Seattle, WA, USA; 3Cleveland Clini...
Saved in:
| Main Authors: | Sarfraz Z, Maharaj A, Venur VA, Lathia JD, Odia Y, Ahluwalia MS |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Clinical Pharmacology: Advances and Applications |
| Subjects: | |
| Online Access: | https://www.dovepress.com/immunotherapy-in-glioblastoma-an-overview-of-current-status-peer-reviewed-fulltext-article-CPAA |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Why Do Glioblastoma Treatments Fail?
by: Alen Rončević, et al.
Published: (2025-02-01) -
Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
by: Yuanyang Sun, et al.
Published: (2025-05-01) -
The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis
by: Zhaoming Song, et al.
Published: (2025-12-01) -
Developing and validating a prognostic disulfidptosis-related signature for glioblastoma: predicting radioresistance and synergestic effect with immunotherapy
by: Chen Chen, et al.
Published: (2025-03-01) -
Lipidic and Inorganic Nanoparticles for Targeted Glioblastoma Multiforme Therapy: Advances and Strategies
by: Ewelina Musielak, et al.
Published: (2025-01-01)